Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 5382
116th Congress(2019-2020)
To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.
Introduced
Introduced
Introduced in House on Dec 10, 2019
Overview
Text
Introduced in House 
Dec 10, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Dec 10, 2019)
Dec 10, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 5382 (Introduced-in-House)


116th CONGRESS
1st Session
H. R. 5382


To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.

IN THE HOUSE OF REPRESENTATIVES

December 10, 2019

Mr. Fortenberry introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

The U.S. Government shall create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.